Shire plc: the Company’s issued ordinary share capital comprised 902,970,965 ordinary shares of 5 pence each
OREANDA-NEWS. Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”), in accordance with 5.6.1R of the Financial Conduct Authority's (the “FCA”) Disclosure Rules and Transparency Rules, notifies the market of the following:
As at September 30, 2016, the Company’s issued ordinary share capital comprised 902,970,965 ordinary shares of 5 pence each with voting rights and a further 7,971,461 ordinary shares held in treasury.
Therefore, the total number of voting rights in the Company is 902,970,965. This is the figure which should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Rules and Transparency Rules.
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.